Richard /ca/ Murray, CEO and President at Jounce Therapeutics, Inc. (JNCE), sold 20,568 shares at $21.21 ($443K) on 2018-03-05, disclosed to the SEC on 2018-03-07.
Open-market sale of $443k JNCE by CEO and President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.21 | 12,100 | $257K | 57.9% |
| 2 | $22.06 | 4,234 | $93K | 21.1% |
| 3 | $22.06 | 4,234 | $93K | 21.1% |
| Total | $21.56 avg | 20,568 | $443K | 100% |
| Filing → |
| JNCE | SELL | 2022-01-11 | $416K | — | Filing → |
| JNCE | SELL | 2021-01-25 | $808K | — | Filing → |
| JNCE | SELL | 2021-01-20 | $1.3M | — | Filing → |